The increasing prevalence of eye diseases, particularly among aging populations, has spurred the demand for retinal imaging devices globally. Moreover, advancements in technology, including the integration of artificial intelligence (AI) and machine learning, have enhanced the diagnostic capabilities of these devices. Accordingly, the global retinal imaging devices market is estimated to garner $9322.89 million by 2032, projecting a CAGR of 5.93% during the forecast period, 2023-2032.
This blog will examine the current competitive landscape of the global retinal imaging devices market –
Leading companies in the retinal imaging devices market have driven innovations, shaping the industry’s competitive landscape. These players have introduced cutting-edge technologies, setting new standards for device accuracy and ease of use.
Strategic Developments by Key Players
- ZEISS will showcase the new ZEISS ATLAS 500ZEISS will showcase the new ZEISS ATLAS 500, a next-generation corneal topography system, at the European Society of Cataract and Refractive Surgery (ESCRS) annual conference from September 8th-12th, 2023, in Vienna, Austria. It combines corneal topography and dry eye assessment tools for intelligent clinical decision-making. It is a multimodality solution for the anterior eye segment. Also, it offers a well-organized, intuitive, and integrated interface for efficient operation. Further, it integrates into the ZEISS cataract and corneal refractive workflows. Says Dr. Edward Boshnick, Specialist in the Non-Surgical Restoration of Quality Vision and Owner of Global Vision Rehabilitation Center, Florida, “With the ATLAS 500 I can easily capture images of my patient’s eye with amazing detail, and it helps me to understand my patient’s dry eye disease.” (Source)
- TOPCON CORPORATION acquires SATEL On 20th June 2023, TOPCON announced the acquisition of SATEL Oy. SATEL is a leading innovator in wireless technology globally. It designs, offers, and manufactures high-quality connectivity solutions that facilitate mission-critical, secure connections using the optimal characteristics of different communication technologies for real-life use cases. Says Ray O’Connor, TOPCON Positioning Systems president and CEO, “As our products and services have evolved from individual measurement tools to complete, multi-node workflow automation solutions, the significance of advanced communication technology has grown. Through this acquisition we are able to secure long term access to a key technology component for our portfolio today and in the future.” (Source)
NIDEK launches NT-1/1e Non Contact Tonometer Models
- On 17th April 2023, NIDEK CO LTD announced the launch of the NT-1/1e Non Contact Tonometer models. The NT-1p/1 is equipped with an air nozzle contact sensor to prioritize patient safety and conduct fully automated measurements. When the patient positions their chin on the chinrest, the device autonomously identifies the eye position and records measurements, eliminating the need for operator intervention.
- While the NT-1e serves as a fundamental model for manual measurements with excellent user-friendliness, it retains the NT-1 series’ standard 3D auto-tracking function, ensuring precise, straightforward, and rapid measurements.
- Motoki Ozawa, President and CEO of NIDEK CO LTD says, “The NT-1 series offers optimal products that satisfy a wide range of customer needs to meet clinical care. Leveraging our expertise in optical technology and engineering, we will continue to develop products that address our customers needs for efficient patient throughput while maintaining a small device footprint ensuring good patient flow at clinical facilities and optical shops.” (Source)
AI facilitates Integrated Product Developments
AI and machine learning algorithms are being integrated into retinal imaging devices to assist healthcare professionals in automating image analysis and detecting abnormalities with greater accuracy. This trend enhances diagnostic capabilities and workflow efficiency.
- AI-Integrated Developments for Eye Scans Researchers from Germany and the United Kingdom are using artificial intelligence (AI) to develop a system that will facilitate widespread testing alongside enhanced efficiency. On 10th June 2023, Dr. Nikolas Pontikos, a group leader at the UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, the UK, presented his team’s development of Eye2Gene at the annual conference of the European Society of Human Genetics. Eye2Gene is an AI system that can identify the genetic cause of inherited retinal diseases (IRDs) Inherited retinal diseases (IRDs) are characterized by single-gene disorders that impact the retina, posing challenges for diagnosis due to alterations in one of several potential candidate genes. Apart from specialized centers, only a limited number of experts possess the requisite expertise in these conditions, creating obstacles for patients seeking access to accurate testing and diagnosis. Says Dr. Pontikos, “Identifying the causative gene from a retinal scan is considered extremely challenging, even by experts. However, the AI is able to achieve this to a higher level of accuracy than most human experts.” (Source)
All in All
Key players and emerging innovators continue to redefine the global retinal imaging devices market’s competitive landscape. As lucrative trends and opportunities continue to unfold, the future of retinal imaging devices promises improved patient care, increased accessibility, and enhanced diagnostic accuracy in the field of ophthalmology. As stakeholders in the healthcare industry, staying abreast of these developments is essential for driving progress and delivering quality eye care.
By Akhil Nair
FAQ
The future trends in the global retinal imaging devices market include the integration of artificial intelligence (AI) for automated image analysis, the expansion of telemedicine and remote patient monitoring applications, and personalized medicine approaches.